Organon Co Stock Price Prediction
| OGN Stock | USD 15.68 0.56 3.70% |
Oversold Vs Overbought
45
Oversold | Overbought |
Quarterly Earnings Growth 5.081 | EPS Estimate Next Quarter 1.03 | EPS Estimate Current Year 4.0985 | EPS Estimate Next Year 4.236 | Wall Street Target Price 22.375 |
Using Organon hype-based prediction, you can estimate the value of Organon Co from the perspective of Organon response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Organon to buy its stock at a price that has no basis in reality. In that case, they are not buying Organon because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Organon after-hype prediction price | USD 15.92 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Organon |
Organon After-Hype Price Prediction Density Analysis
As far as predicting the price of Organon at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Organon or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Organon, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Organon Estimiated After-Hype Price Volatility
In the context of predicting Organon's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Organon's historical news coverage. Organon's after-hype downside and upside margins for the prediction period are 13.88 and 17.96, respectively. We have considered Organon's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Organon is very steady at this time. Analysis and calculation of next after-hype price of Organon is based on 3 months time horizon.
Organon Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Organon is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Organon backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Organon, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.37 | 2.05 | 0.25 | 0.04 | 11 Events / Month | 9 Events / Month | In about 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
15.68 | 15.92 | 1.53 |
|
Organon Hype Timeline
On the 12th of December 2024 Organon is traded for 15.68. The entity has historical hype elasticity of 0.25, and average elasticity to hype of competition of 0.04. Organon is forecasted to increase in value after the next headline, with the price projected to jump to 15.92 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 1.53%, whereas the daily expected return is now at -0.37%. The volatility of related hype on Organon is about 1892.31%, with the expected price after the next announcement by competition of 15.72. The company reported the last year's revenue of 6.26 B. Total Income to common stockholders was 1.02 B with profit before taxes, overhead, and interest of 3.89 B. Considering the 90-day investment horizon the next forecasted press release will be in about 11 days. Check out Organon Basic Forecasting Models to cross-verify your projections.Organon Related Hype Analysis
Having access to credible news sources related to Organon's direct competition is more important than ever and may enhance your ability to predict Organon's future price movements. Getting to know how Organon's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Organon may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| JNJ | Johnson Johnson | (0.48) | 7 per month | 0.00 | (0.40) | 1.40 | (1.55) | 3.25 | |
| BMY | Bristol Myers Squibb | 0.54 | 6 per month | 1.20 | 0.09 | 2.23 | (2.07) | 14.39 | |
| ABBV | AbbVie Inc | (3.64) | 8 per month | 0.00 | (0.14) | 2.30 | (2.39) | 18.93 | |
| LLY | Eli Lilly and | 1.74 | 6 per month | 0.00 | (0.16) | 2.71 | (3.47) | 9.21 | |
| PFE | Pfizer Inc | (0.22) | 6 per month | 0.00 | (0.24) | 2.07 | (2.25) | 8.17 | |
| AMGN | Amgen Inc | 2.45 | 8 per month | 0.00 | (0.23) | 1.85 | (4.16) | 9.43 | |
| MRK | Merck Company | 2.06 | 7 per month | 0.00 | (0.27) | 2.00 | (2.17) | 5.18 | |
| GILD | Gilead Sciences | (0.99) | 8 per month | 1.14 | 0.09 | 2.17 | (1.82) | 10.80 | |
| SNY | Sanofi ADR | 0.15 | 8 per month | 0.00 | (0.36) | 1.13 | (1.85) | 7.81 | |
| AZN | AstraZeneca PLC ADR | (0.02) | 8 per month | 0.00 | (0.27) | 1.32 | (2.78) | 8.50 | |
| NVS | Novartis AG ADR | (0.36) | 7 per month | 0.00 | (0.37) | 1.12 | (1.52) | 6.05 | |
| BIIB | Biogen Inc | 0.07 | 9 per month | 0.00 | (0.36) | 1.97 | (2.60) | 6.36 |
Organon Additional Predictive Modules
Most predictive techniques to examine Organon price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Organon using various technical indicators. When you analyze Organon charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Organon Predictive Indicators
The successful prediction of Organon stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Organon Co, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Organon based on analysis of Organon hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Organon's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Organon's related companies. | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.0409 | 0.0799 | 0.0839 | Price To Sales Ratio | 1.15 | 0.59 | 0.77 |
Story Coverage note for Organon
The number of cover stories for Organon depends on current market conditions and Organon's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Organon is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Organon's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Organon Short Properties
Organon's future price predictability will typically decrease when Organon's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Organon Co often depends not only on the future outlook of the potential Organon's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Organon's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 256.3 M | |
| Cash And Short Term Investments | 693 M |
Check out Organon Basic Forecasting Models to cross-verify your projections. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organon. If investors know Organon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organon listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 5.081 | Dividend Share 1.12 | Earnings Share 5.05 | Revenue Per Share 24.984 | Quarterly Revenue Growth 0.041 |
The market value of Organon is measured differently than its book value, which is the value of Organon that is recorded on the company's balance sheet. Investors also form their own opinion of Organon's value that differs from its market value or its book value, called intrinsic value, which is Organon's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organon's market value can be influenced by many factors that don't directly affect Organon's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Organon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.